Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alcon Inc (NY: ALC )

85.99 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc

< Previous 1 2 3 4 5 6 7 Next >
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE: 
Via Benzinga
Analyst Ratings For Alcon
Alcon (NYSE:ALC) has observed the following analyst ratings within the last qu... 
Via Benzinga
Expert Ratings For Alcon
Within the last quarter, Alcon (NYSE:ALC) has observed the following analyst ... 
Via Benzinga
Where Alcon Stands With Analysts
Analysts have provided the following ratings for Alcon (NYSE:ALC) within the ... 
Via Benzinga
Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe
From Alcon Inc. Investors
Via Business Wire
Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism
From Alcon Inc. Investors
Via Business Wire
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
From Alcon Inc. Investors
Via Business Wire
Where Alcon Stands With Analysts
Within the last quarter, Alcon (NYSE:ALC) has observed the following analyst r... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
Alcon inc (ALC) Q3 2021 Earnings Call Transcript
ALC earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Alcon Reports Third Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021
From Alcon Inc. Corporate
Via Business Wire
Alcon Strengthens Surgical Glaucoma Portfolio With $475M Ivantis Deal
Alcon AG (NYSE: ALC) has agreed to acquire Ivantis Inc for $475 million. Alcon may be required to make additional contingent payments upon the achievement of... 
Via Benzinga
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
From Alcon Inc. Investors
Via Business Wire
Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs
From Alcon Inc. Corporate
Via Business Wire
Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care
From Alcon Inc. Corporate
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021
Upgrades Northland Capital Markets upgraded the previous rating for Five9 Inc (NASDAQ: 
Via Benzinga
Alcon Honored with FutureEdge 50 Award
From Alcon Inc. Corporate
Via Business Wire
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
Closed-End Fund Favorites For Global Investing
Calamos Global Total Return Fund is a four-star-rated fund. It seeks total return through a combination of capital appreciation and current income, largely through investment in a globally diversified... 
Via Talk Markets
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
Exposures COVID-19
10 Biggest Price Target Changes For Thursday
Needham boosted the price target on NVIDIA Corporation (NASDAQ: 
Via Benzinga
Stocks That Hit 52-Week Highs On Monday
Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG... 
Via Benzinga
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high... 
Via Benzinga
46 Biggest Movers From Yesterday
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67... 
Via Benzinga
Alcon inc (ALC) Q2 2021 Earnings Call Transcript
ALC earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Mid-Afternoon Market Update: Crude Oil Down 1.5%; Tuya Shares Plummet
Toward the end of trading Wednesday, the Dow traded down 0.27% to 35,249.25 while the NASDAQ rose 0.06% to 14,664.67. The S&P also fell, dropping 0.21% to 4,438.73. The U.S.... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide
Midway through trading Wednesday, the Dow traded down 0.12% to 35,299.82 while the NASDAQ fell 0.01% to 14,654.93. The S&P also fell, dropping 0.10% to 4,443.63. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
34 Stocks Moving In Wednesday's Mid-Day Session
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $... 
Via Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares rose 50.6% to $23.12 in pre-market trading. Virpax Pharmaceuticals shares jumped 265% on Tuesday after the company... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.